Search results
Results from the WOW.Com Content Network
The book addresses misinformation related to vaccination, and asks how vaccine rumors start and why they do not go away. [1] [4] Looking chiefly at high-income countries, the book examines social, political, psychological and cultural factors that make up the various mind-sets to vaccination. [2]
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group and owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group. [110] Novartis's businesses are divided into two operating divisions: Innovative Medicines and Sandoz (generics). [111]
Novartis today announced positive clinical trial results for its vaccine for the H7N9 avian flu, marking the first major step made by a large pharmaceutical company in treating the virus.
A government agency was spreading dangerous rumors about the coronavirus vaccine, playing on people's religious beliefs to sow chaos, ... Vaccines became a political issue in May 2020, when the ...
The same survey found that 13% of Americans believe vaccines can cause autism, up from 6% in 2015, and roughly half of Americans are unsure if vaccines cause autism. Just 36% understand that ...
The World Health Organization has classified vaccine related misinformation into five topic areas. These are: threat of disease (vaccine preventable diseases are harmless), trust (questioning the trustworthiness of healthcare authorities who administer vaccines), alternative methods (such as alternative medicine to replace vaccination), effectiveness (vaccines do not work) and safety (vaccines ...
The Novartis vaccine, Novavax, which is based on the more traditional way to make vaccines, fights primarily an earlier variant, JN.1, but it, too, should offer good protection, Hrisomalos said.